FDA Approves Dupixent (Dupilumab) as First Biologic Atopic Dermatitis Treatment for Kids 5 and Under
One of the most vexing things about having a young child with atopic dermatitis (eczema) is figuring out how to help them when topical treatments don’t work. Now there’s an entirely new option to try with Dupixent (dupilumab), a once-monthly injection that parents can give kids at home.In June 2022 the U.S. Food and Drug Administration (FDA) approved Dupixent to treat moderate-to-severe atopic dermatitis in children 6 months to 5 years old who haven’t achieved enough symptom relief with prescription corticosteroid creams or ointments, according to a statement from the drug’s developers, Sanofi and Regeneron.More than 1 in 10 Americans have atopic dermatitis, which is much more common in children and typically develops before kids are 5 years old, according to the American Academy of Dermatology (AAD).Around a third of…